(Q43698175)

26 November 2017

Changes in rat serum corticosterone after treatment with metabotropic glutamate receptor agonists or antagonists (English)

1 reference

26 November 2017

M P Johnson

1

1 reference

PubMed ID

11489083

26 November 2017

G Kelly

series ordinal

2

1 reference

PubMed ID

11489083

26 November 2017

M Chamberlain

series ordinal

3

1 reference

26 November 2017

1 August 2001

1 reference

Journal of Neuroendocrinology

26 November 2017

1 reference

26 November 2017

13

1 reference

26 November 2017

670-677

1 reference

26 November 2017

8

1 reference

Glutamate, the dominant excitatory transmitter in neuroendocrine regulation.

26 November 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

Glutamate: a major excitatory transmitter in neuroendocrine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

Differential control of glucoregulatory hormone response and glucose metabolism by NMDA and kainate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

Central NMDA enhances hepatic glucose output and non-insulin-mediated glucose uptake by a nonadrenergic mechanism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

N-Methyl-D-Aspartate Treatment Increases Circulating Adrenocorticotropin and Luteinizing Hormone in the Rat*

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

Pharmacological agents acting at subtypes of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

Metabotropic glutamate receptor in vasopressin, CRF and VIP hypothalamic neurones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

Phosphoinositide hydrolysis in vivo with group I metabotropic glutamate receptor agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

LY354740 is a potent and highly selective group II metabotropic glutamate receptor agonist in cells expressing human glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

LY354740: a metabotropic glutamate receptor agonist which ameliorates symptoms of nicotine withdrawal in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

In vivo inhibition of veratridine-evoked release of striatal excitatory amino acids by the group II metabotropic glutamate receptor agonist LY354740 in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

LY341495 is a nanomolar potent and selective antagonist of group II metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

The potent mGlu receptor antagonist LY341495 identifies roles for both cloned and novel mGlu receptors in hippocampal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

The effects of GABAA receptor blockade in the dorsomedial hypothalamic nucleus on corticotrophin (ACTH) and corticosterone secretion in male rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

Selective forebrain fiber tract lesions implicate ventral hippocampal structures in tonic regulation of paraventricular nucleus corticotropin-releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

A temporal study of post-adrenalectomy increase in ACTH secretion in the rat: effect of various hypothalamic deafferentations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2826.2001.00678.X

10.1046/J.1365-2826.2001.00678.X

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference

PubMed ID

11489083